The FDA requires generic drugs to meet the same safety and effectiveness standards as brand-name drugs. Learn how bioequivalence, manufacturing rules, and strict testing ensure generics work just as well-without the high cost.
Keep Reading
DOACs like apixaban and rivaroxaban offer fewer bleeding risks and no need for blood tests compared to warfarin, making them the preferred choice for most patients. Learn who still needs warfarin and how to choose the safest option.
Keep Reading
QD and QID are dangerous prescription abbreviations that cause deadly dosing errors. Learn how they're misread, who's most at risk, and how healthcare systems and patients can prevent them with simple, proven changes.
Keep Reading
Therapeutic Equivalence Codes (TE Codes) tell pharmacists which generic drugs can be safely swapped for brand-name versions. Learn how the FDA's Orange Book system ensures safety, saves billions, and works in every U.S. pharmacy.
Keep Reading
Not all drugs have authorized generics - and when they do, it's often a strategic move by brand manufacturers, not a benefit to consumers. Learn why most medications still cost too much.
Keep Reading
Macrolide antibiotics like azithromycin can prolong the QT interval, raising the risk of dangerous heart rhythms. Learn who needs an ECG before taking them - and why skipping screening can be risky.
Keep Reading
Antiretroviral HIV medications suppress the virus effectively - but drug interactions and resistance can undermine treatment. Learn how modern regimens work, why resistance develops, and what’s next in HIV care.
Keep Reading
Doxepin is a quiet but effective option for treating depression and anxiety in older adults, especially when sleep problems are involved. It offers a balance of mood and sleep benefits with fewer risks than many alternatives.
Keep Reading
Compare Actos (pioglitazone) with modern diabetes alternatives like metformin, SGLT2 inhibitors, and GLP-1 agonists. Learn which options are safer, more effective, and better for heart and kidney health.
Keep Reading
A practical side‑by‑side comparison of Ivermectin and its main alternatives, covering efficacy, safety, cost and how to choose the right drug for specific conditions.
Keep Reading